Thyroid Cancer No Surgery 101: Radiofrequency Ablation RFA for Treatment of Locally Recurrent Thyroid Cancers Smaller Than 2 Cm.
Comments by Dr.G.
The use of a minimally invasive interventional thyroid system RFA can be effective and a safe way to avoid the repeat surgeries that have increased risk of complications,especially parathyroid dysfunction with post op hypocalcemia which in this study never happened with RFA treated group of 73 patients.
The complication rate for RFA was low 3.3% and major complications 1.4% or sequelae was only 0.14%.
Hypocalcemia was nor seen in any of the 73 RFA treated cancer patients. Clinical findings with low calcium soon below.
Famous Drawings by Frank Netter show the effects of hypocalcemia.
1.A study by Kim et al evaluated the efficacy and safety of radiofrequency ablation for localized small recurrent thyroid cancers less than 2 cm by comparing them with those at repeat surgery.
2. 73 patients with recurrent thyroid cancer who had been treated with (RFA) or repeat surgery.
3. Recurrence-free survival rates and post-treatment complication rates were compared between RFA and reoperation groups.
4.The 1- and 3-year recurrence-free survival rates and post-treatment hoarseness rates were comparable for RFA and reoperation groups.
5. Post-treatment hypocalcemia occurred exclusively in the reoperation group.
6 RFA may be an effective and safe alternative to repeat surgery in patients with locally recurrent small thyroid cancers.
Kim JH et al
RFA can also be used in combination with External beam to shrink thyroid cancer and relieve airway obstruction as seen in this case from Dr.JH Bek for Seoul Korea.
Santa Monica Thyroid Center’s Richard Guttler is dedicated to the use on alternatives to surgery when they are safe and work.
Thyroid RFA is available to patients willing to travel to Korea to be treated as it is not Available yet in the US. A candidate evaluation by Dr.G. can determine if thyroid RFA is right for you. call Matt at 310-393-9960 or email@example.com for referral evaluation details.
Richard Guttler MD,FACE,ECNU